NASDAQ:QTNT

Quotient Stock Forecast, Price & News

$2.89
+0.05 (+1.76 %)
(As of 09/17/2021 01:50 PM ET)
Add
Compare
Today's Range
$2.80
$3.03
50-Day Range
$2.74
$3.77
52-Week Range
$2.63
$7.59
Volume51,668 shs
Average Volume619,061 shs
Market Capitalization$293.59 million
P/E RatioN/A
Dividend YieldN/A
Beta2.31
30 days | 90 days | 365 days | Advanced Chart
Receive QTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for Quotient and its competitors with MarketBeat's FREE daily newsletter.


Quotient logo

About Quotient

Quotient Ltd. is a commercial-stage diagnostics company, which provides immunohematology products to hospitals and blood banks. Its products and services include MOSAIQ and ALBA. The firm develops, manufactures, and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. The company was founded on January 18, 2012 and is headquartered in Eysins, Switzerland.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.91 out of 5 stars

Medical Sector

651st out of 1,351 stocks

Diagnostic Substances Industry

10th out of 25 stocks

Analyst Opinion: 3.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Quotient (NASDAQ:QTNT) Frequently Asked Questions

Is Quotient a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Quotient in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Quotient stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QTNT, but not buy additional shares or sell existing shares.
View analyst ratings for Quotient
or view top-rated stocks.

What stocks does MarketBeat like better than Quotient?

Wall Street analysts have given Quotient a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Quotient wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Quotient's next earnings date?

Quotient is scheduled to release its next quarterly earnings announcement on Monday, November 1st 2021.
View our earnings forecast for Quotient
.

How were Quotient's earnings last quarter?

Quotient Limited (NASDAQ:QTNT) issued its quarterly earnings data on Thursday, August, 5th. The company reported ($0.24) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.26) by $0.02. Quotient had a negative net margin of 246.74% and a negative trailing twelve-month return on equity of 6,699.81%.
View Quotient's earnings history
.

How has Quotient's stock been impacted by COVID-19 (Coronavirus)?

Quotient's stock was trading at $4.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, QTNT stock has decreased by 37.7% and is now trading at $2.89.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for QTNT?

1 brokerages have issued 12 month price objectives for Quotient's shares. Their forecasts range from $4.50 to $4.50. On average, they expect Quotient's share price to reach $4.50 in the next year. This suggests a possible upside of 55.7% from the stock's current price.
View analysts' price targets for Quotient
or view top-rated stocks among Wall Street analysts.

Who are Quotient's key executives?

Quotient's management team includes the following people:
  • Manuel O. Méndez Muñiz, Chief Executive Officer & Director
  • Peter Buhler, Chief Financial Officer
  • Jeremy Alexander Stackawitz, Chief Commercial Officer

Who are some of Quotient's key competitors?

What other stocks do shareholders of Quotient own?

What is Quotient's stock symbol?

Quotient trades on the NASDAQ under the ticker symbol "QTNT."

Who are Quotient's major shareholders?

Quotient's stock is owned by a variety of institutional and retail investors. Top institutional investors include Credit Suisse AG (6.49%), BlackRock Inc. (5.56%), Highbridge Capital Management LLC (4.79%), Clearbridge Investments LLC (3.92%), Morgan Stanley (3.43%) and Morgan Stanley (3.43%). Company insiders that own Quotient stock include Edward Farrell, Jeremy Stackawitz, Perceptive Advisors Llc, Peter Buhler and Prondzynski Heino Von.
View institutional ownership trends for Quotient
.

Which major investors are selling Quotient stock?

QTNT stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Highbridge Capital Management LLC, Vanguard Group Inc., TimesSquare Capital Management LLC, Castleark Management LLC, Victory Capital Management Inc., Sei Investments Co., and Los Angeles Capital Management LLC.
View insider buying and selling activity for Quotient
or view top insider-selling stocks.

Which major investors are buying Quotient stock?

QTNT stock was bought by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Artisan Partners Limited Partnership, Credit Suisse AG, Geode Capital Management LLC, Nuveen Asset Management LLC, Premier Asset Management LLC, and Northern Trust Corp. Company insiders that have bought Quotient stock in the last two years include Perceptive Advisors Llc, Peter Buhler, and Prondzynski Heino Von.
View insider buying and selling activity for Quotient
or or view top insider-buying stocks.

How do I buy shares of Quotient?

Shares of QTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quotient's stock price today?

One share of QTNT stock can currently be purchased for approximately $2.89.

How much money does Quotient make?

Quotient has a market capitalization of $293.59 million and generates $43.38 million in revenue each year. The company earns $-108,470,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis.

How many employees does Quotient have?

Quotient employs 435 workers across the globe.

What is Quotient's official website?

The official website for Quotient is www.quotientbd.com.

Where are Quotient's headquarters?

Quotient is headquartered at B1 Business Park Terre Bonne Route de Crassier 13, Eysins Y9, 1262.

How can I contact Quotient?

Quotient's mailing address is B1 Business Park Terre Bonne Route de Crassier 13, Eysins Y9, 1262. The company can be reached via phone at (122) 716-9800 or via email at [email protected]


This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.